Brief: Curasight Announces Approval Of Clinical Trial Application For Phase 2 Trial With Utrace In Prostate Cancer Patients
16/04/2024 19:41
April 16 (Reuters) - Curasight A/S CURAS.TE :
* CURASIGHT ANNOUNCES APPROVAL OF CLINICAL TRIAL APPLICATION
(CTA)
FOR PHASE 2 TRIAL WITH UTRACE ® IN PROSTATE CANCER PATIENTS
* CURASIGHT A/S - DOSING OF FIRST PATIENT EXPECTED 2Q 2024
Source text for Eikon: ID:nWkr1MhD0m
Further company coverage: CURAS.TE
((Reuters.Briefs@thomsonreuters.com;))